BioCardia Inc [NASDAQ: BCDA] traded at a low on 2025-09-18, posting a -23.78 loss after which it closed the day’ session at $1.17.
The results of the trading session contributed to over 19855111 shares changing hands. Over the past one week, the price volatility of BioCardia Inc stands at 13.86% while the volatility over the past one month is 6.66%.
The market cap for BCDA stock reached $6.80 million, with 5.50 million shares outstanding and 4.05 million shares in the current float. Compared to the average trading volume of 319.74K shares, BCDA reached a trading volume of 19855111 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioCardia Inc [BCDA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BCDA shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BCDA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Dawson James have made an estimate for BioCardia Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 16, 2021.
How has BCDA stock performed recently?
BioCardia Inc [BCDA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -48.46. With this latest performance, BCDA shares dropped by -37.43% in over the last four-week period, additionally sinking by -54.65% over the last 6 months – not to mention a drop of -46.33% in the past year of trading.
BioCardia Inc (BCDA) Capital Structure & Debt Analysis
BioCardia Inc (BCDA) Efficiency & Liquidity Metrics
BioCardia Inc (BCDA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, BioCardia Inc. (BCDA) effectively leverages its workforce, generating an average of -$439500.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.33% and a Quick Ratio of 0.33%, indicating strong ability to cover short-term liabilities.
Earnings analysis for BioCardia Inc [BCDA]
With the latest financial reports released by the company, BioCardia Inc posted -0.61/share EPS, while the average EPS was predicted by analysts to be reported at -1.19/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.58. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BCDA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for BioCardia Inc go to 31.06%.
Insider trade positions for BioCardia Inc [BCDA]
There are presently around $5.25%, or 6.48%% of BCDA stock, in the hands of institutional investors.
